Literature DB >> 30279247

Autoimmune autonomic ganglionopathy associated with Sjögren's syndrome presenting with recurrent abdominal distension.

Takeshi Yoshida1, Mitsuyo Kinjo2, Shunya Nakane3.   

Abstract

A 65-year-old woman with Sjögren's syndrome presented with recurrent abdominal distension, constipation, weight loss, orthostatic dizziness, loss of sweating and incomplete emptying of the bladder. Gastrointestinal dilatation but no evidence of malignancy or obstruction was found on CT of the abdomen, oesophagogastroduodenoscopy or colonoscopy. Postvoiding residual urine volume was increased. Antiganglionic acetylcholine receptor antibody was positive. We diagnosed as autoimmune autonomic ganglionopathy. The patient responded to corticosteroid treatment. One year after treatment, she continued to have mild gastrointestinal symptoms, but overall condition was stable without further intervention. © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  neurogastroenterology; sjogren’s syndrome

Mesh:

Substances:

Year:  2018        PMID: 30279247     DOI: 10.1136/bcr-2017-223785

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  3 in total

1.  Autoimmune Gastrointestinal Dysmotility in a Patient With HIV Treated With Methylprednisolone and Pyridostigmine.

Authors:  Christopher M Gromisch; Mariana A Machado; Venkata Satyam; David Nunes
Journal:  ACG Case Rep J       Date:  2021-07-21

2.  Detecting gastrointestinal manifestations in patients with systemic sclerosis using anti-gAChR antibodies.

Authors:  Shunya Nakane; Masataka Umeda; Shin-Ya Kawashiri; Akihiro Mukaino; Kunihiro Ichinose; Osamu Higuchi; Yasuhiro Maeda; Hideki Nakamura; Hidenori Matsuo; Atsushi Kawakami
Journal:  Arthritis Res Ther       Date:  2020-02-21       Impact factor: 5.156

3.  Microscopic colitis: controversies in clinical symptoms and autoimmune comorbidities.

Authors:  Istvan Fedor; Eva Zold; Zsolt Barta
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.